Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
xtandi - Google News
Get the latest updates from xtandi - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
Progressives Hand Biden List of 55 Executive Actions Because 'Working People Can't Wait' - Common Dreams
about 2 years ago
Progressives Hand Biden List of 55 Executive Actions Because 'Working People Can't...
Merck looks for a return on its Lynparza investment - Vantage
about 2 years ago
Merck looks for a return on its Lynparza investment Vantage
Cancer Therapeutics Market Size, Share, Trend Analysis By Growth, Emerging Trends and Future Opportunities – The Bite - The Bite
about 2 years ago
Cancer Therapeutics Market Size, Share, Trend Analysis By Growth, Emerging Trends and...
Merck Stops Trial of Pembrolizumab Plus Olaparib in Metastatic Castration-Resistant Prostate Cancer - Pharmacy Times
about 2 years ago
Merck Stops Trial of Pembrolizumab Plus Olaparib in Metastatic Castration-Resistant Prostate Cancer...
Biotech execs who pinched Genentech trade secrets headed to prison - FiercePharma
about 2 years ago
Biotech execs who pinched Genentech trade secrets headed to prison FiercePharma
Rare Setback For Merck & Co And AstraZeneca's Keytruda-Lynparza Combo In Prostate Cancer - Scrip
about 2 years ago
Rare Setback For Merck & Co And AstraZeneca's Keytruda-Lynparza Combo In Prostate...
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data - FiercePharma
about 2 years ago
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month...
MHRA request about ultrasound activation system holds up Exact Therapeutics' solid tumor trial - FiercePharma
about 2 years ago
MHRA request about ultrasound activation system holds up Exact Therapeutics' solid tumor...
Merck Stops Trial After Analysis Reveals Keytruda Plus Lynparza Was Ineffective in Prostate Cancer Treatment - Curetoday.com
about 2 years ago
Merck Stops Trial After Analysis Reveals Keytruda Plus Lynparza Was Ineffective in...
Merck (MRK) Stops Keytruda-Lynparza Combo Prostate Cancer Study - Nasdaq
about 2 years ago
Merck (MRK) Stops Keytruda-Lynparza Combo Prostate Cancer Study Nasdaq
Prostate Cancer Drugs Global Market Report 2022 - GlobeNewswire
about 2 years ago
Prostate Cancer Drugs Global Market Report 2022 GlobeNewswire
Prostate Cancer Drugs Global Market Report 2022 - Yahoo Finance
about 2 years ago
Prostate Cancer Drugs Global Market Report 2022 Yahoo Finance